Lower serum SFRP5 levels are associated with carotid atherosclerosis in patients with essential hypertension.
文献摘要
Objective To investigate the variation in serum secreted frizzled-related protein 5 (SFRP5) levels among individuals with essential hypertension and its association with carotid atherosclerosis. Methods 297 subjects were included: 77 with stage 1 hypertension, 73 with stage 2, 67 with stage 3, and 80 normotensive controls. Logistic regression analyses alongside receiver operating characteristic (ROC) curve examinations were used to determine the independent relationship and predictive significance of SFRP5 in relation to carotid atherosclerosis. The primary outcome measure was serum SFRP5 level. Secondary outcome measures included levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), carotid intima-media thickness (CIMT), and incidence of carotid plaque. Results Serum SFRP5 levels decreased significantly with increasing hypertension severity and were lower in patients with carotid atherosclerosis (P Conclusion Lower serum SFRP5 levels are associated with hypertension severity and heightened risk of carotid atherosclerosis in hypertensive patients. SFRP5 may be a biomarker for risk assessment and may also represent a promising therapeutic target. Additional studies are required to validate these results and unravel the underlying mechanisms.